ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00907452
Recruitment Status : Unknown
Verified June 2011 by Intergroupe Francophone du Myelome.
Recruitment status was:  Active, not recruiting
First Posted : May 22, 2009
Last Update Posted : June 21, 2011
Sponsor:
Information provided by:
Intergroupe Francophone du Myelome

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2011
  Study Completion Date : No date given